Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Vision and vision-related outcome measures in multiple sclerosis.
EDITORIAL Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention.
Social network diversity and white matter microstructural integrity in humans.
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study.
The HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical Practice.
Total glucosides of peony attenuates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis.
The Subventricular Zone is Able to Respond to a Demyelinating Lesion after Localized Radiation.
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.
Role of Autoantibodies in Acquired Inflammatory Demyelinating Diseases of the Central Nervous System in Children.
Mimotopic peptide immunotherapy for the treatment of multiple sclerosis, an inflammatory autoimmune disease.
Pharmacogenomics of interferon beta and glatiramer acetate response: A review of the literature.
The new era of multiple sclerosis therapy.
An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in Multiple Sclerosis.
Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
Neuronal Hemoglobin Expression and Its Relevance to Multiple Sclerosis Neuropathology.
Modeling the course and outcomes of MS is statistical twaddle-No.
Expression Profile of Long Noncoding RNAs in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients.
Patterns of Nonrandom Mating Within and Across 11 Major Psychiatric Disorders.
A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders.
Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment.
Age-effects in white matter using associated diffusion tensor imaging and magnetization transfer ratio during late childhood and early adolescence.
Identification of the Interaction Between the Human Homologue of the Arabidopsis COP9 Signalosome Subunit 7a and Olig1.
Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): Evidence of increasing risk in the south of Europe.
Pages
« first
‹ previous
…
608
609
610
611
612
613
614
615
616
…
next ›
last »